References
- Taylor CR, Sober AJ. Sun exposure and skin disease. Annu Rev Med 1996; 47: 181–91.
- Nicol NH, Fenske NA. Photodamage: cause, clinical manifestations, and prevention. Dermatol Nurs 1993; 5: 263–76.
- Moy RL. Clinical presentation of actinic keratosis and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: S8–S10.
- Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ('actinic keratosis'). J Am Acad Dermatol 2000; 42: S11–S17.
- Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42: S23–S24.
- Guenther ST, Hurwitz RM, Buckel LJ. Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: a clinicopathologic correlation. J Am Acad Dermatol 1999; 41: 443–48.
- Feldman SR, Fleischer AB, Williford PM, et al. Destructive procedures are the standard of care for the treatment of actinic keratosis. J Am Acad Dermatol1999; 40: 43–47.
- Data on fileLevulan1 Kerastick2 (aminolevulinic acid HCL) for topical solution 20%. DUSA Pharmaceuticals Inc., Wilmington, MA, USA.
- De Rosa FS, Bentley MVLB. Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives. Pharm Res 2000; 17: 1447–55.
- Szemies RM, Calzavara-Pinton P, Karrer S, et al. Topical photodynamic therapy in dermatology. J Photochem Photobiol B 1996; 36: 213–19.